- authorisedTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
This study is testing a new medicine, ALKS 2680, for adults with Narcolepsy Type 1. Researchers want to see if it helps reduce sleepiness and is safe. Some people will get the new medicine, and others will get a dummy medicine (placebo).
Italy · France · Netherlands - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 1
This study is testing a new medicine, ALKS 2680, for people with Narcolepsy Type 1. It aims to see how safe the medicine is and how well different doses work to help with symptoms like extreme sleepiness.
Czechia · Italy · France